Climb Bio Inc (NASDAQ: CLYM) is -15.93% lower on its value in year-to-date trading and has touched a low of $1.86 and a high of $11.55 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLYM stock was last observed hovering at around $1.98 in the last trading session, with the day’s gains setting it 0.29%.
Currently trading at $2.27, the stock is -15.16% and -32.65% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing 14.65% at the moment leaves the stock -59.86% off its SMA200. CLYM registered -15.61% loss for a year compared to 6-month loss of -69.85%. The firm has a 50-day simple moving average (SMA 50) of $3.4273 and a 200-day simple moving average (SMA200) of $5.6563.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -26.30% gain in the last 1 month and extending the period to 3 months gives it a -54.60%, and is 12.10% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.42% over the week and 8.32% over the month.
Climb Bio Inc (CLYM) has around 9 employees, a market worth around $152.59M and $0.00M in sales. Distance from 52-week low is 22.04% and -80.35% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.59%).
The shares outstanding are 67.22M, and float is at 51.52M with Short Float at 9.57%.
Climb Bio Inc (CLYM) Insider Activity
The most recent transaction is an insider sale by Pimblett Emily, the company’s CHIEF ACCOUNTING OFFICER. SEC filings show that Pimblett Emily sold 1,235 shares of the company’s common stock on Dec 19 ’24 at a price of $2.02 per share for a total of $2495.0. Following the sale, the insider now owns 11329.0 shares.
Climb Bio Inc disclosed in a document filed with the SEC on Sep 20 ’24 that Pimblett Emily (CHIEF ACCOUNTING OFFICER) sold a total of 1,191 shares of the company’s common stock. The trade occurred on Sep 20 ’24 and was made at $8.18 per share for $9741.0. Following the transaction, the insider now directly holds 7564.0 shares of the CLYM stock.
Still, SEC filings show that on Jul 22 ’24, Morisset Valerie (EVP, R&D AND CSO) disposed off 69,005 shares at an average price of $8.03 for $0.55 million. The insider now directly holds 31,317 shares of Climb Bio Inc (CLYM).
